| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |